{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T19:16:32Z","timestamp":1774811792570,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007083","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000}}],"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["BSSGI0_155851"],"award-info":[{"award-number":["BSSGI0_155851"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["174281"],"award-info":[{"award-number":["174281"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health (US)","award":["2U01AI069924"],"award-info":[{"award-number":["2U01AI069924"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007083","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T22:29:30Z","timestamp":1561415370000},"page":"e1007083","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-1929","authenticated-orcid":true,"given":"Anthony","family":"Hauser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kusejko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh F.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Wandeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Riou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5674-5114","authenticated-orcid":true,"given":"Fardo","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Egger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9220-8348","authenticated-orcid":true,"given":"Roger D.","family":"Kouyos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"ref1","unstructured":"UNAIDS. South Africa | UNAIDS data [Internet]. [cited 26 Jun 2018]. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/en\/regionscountries\/countries\/southafrica\" xlink:type=\"simple\">http:\/\/www.unaids.org\/en\/regionscountries\/countries\/southafrica<\/ext-link>"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1002468","DOI":"10.1371\/journal.pmed.1002468","article-title":"Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study. Suthar AB, editor","volume":"14","author":"LF Johnson","year":"2017","journal-title":"PLOS Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11633630-000000000-00000","article-title":"HIV-1 Antiretroviral Resistance","volume":"72","author":"MW Tang","year":"2012","journal-title":"Drugs"},{"key":"ref4","unstructured":"WHO. WHO | HIV drug resistance report 2017 [Internet]. WHO. World Health Organization; 2017. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/drugresistance\/hivdr-report-2017\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/drugresistance\/hivdr-report-2017\/en\/<\/ext-link>"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.4102\/sajhivmed.v18i1.776","article-title":"Adult antiretroviral therapy guidelines 2017","volume":"18","author":"G Meintjes","year":"2017","journal-title":"South Afr J HIV Med"},{"key":"ref6","article-title":"An ambitious treatment target to help end the AIDS epidemic","year":"2014","journal-title":"An ambitious treatment target to help end the AIDS epidemic"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1001245","DOI":"10.1371\/journal.pmed.1001245","article-title":"HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa","volume":"9","author":"JW Eaton","year":"2012","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/QAD.0b013e328360a4e5","article-title":"Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study","volume":"27","author":"J Estill","year":"2013","journal-title":"AIDS"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/QAD.0000000000000082","article-title":"Predicted levels of HIV drug resistance","volume":"28","author":"V Cambiano","year":"2014","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jix089","article-title":"Impact of HIV Drug Resistance on HIV\/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub\u2013Saharan Africa","volume":"215","author":"AN Phillips","year":"2017","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1126\/science.1090727","article-title":"Unifying the Epidemiological and Evolutionary Dynamics of Pathogens","volume":"303","author":"BT Grenfell","year":"2004","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"20140566","DOI":"10.1098\/rspb.2014.0566","article-title":"The path of least resistance: aggressive or moderate treatment?","volume":"281","author":"RD Kouyos","year":"2014","journal-title":"Proc R Soc B Biol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.epidem.2014.12.003","article-title":"Five challenges in evolution and infectious diseases","volume":"10","author":"CJE Metcalf","year":"2015","journal-title":"Epidemics"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/ije\/dyr080","article-title":"Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa","volume":"41","author":"M Egger","year":"2012","journal-title":"Int J Epidemiol"},{"key":"ref15","article-title":"NNRTI Resistance Notes\u2014HIV Drug Resistance Database","journal-title":"NNRTI Resistance Notes\u2014HIV Drug Resistance Database"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/QAD.0000000000000721","article-title":"Rates of HIV testing and diagnosis in South Africa","volume":"29","author":"LF Johnson","year":"2015","journal-title":"AIDS"},{"key":"ref17","article-title":"Thembisa version 4.1: A model for evaluating the impact of HIV\/AIDS in South Africa","author":"LF Johnson","year":"2018","journal-title":"Thembisa version 4.1: A model for evaluating the impact of HIV\/AIDS in South Africa"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.7196\/SAMJ.2017.v107i12.12776","article-title":"Lamivudine monotherapy in children and adolescents: The devil is in the detail","volume":"107","author":"L Fairlie","year":"2017","journal-title":"South African Med J"},{"key":"ref19","article-title":"Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern","author":"L Muri","year":"2016"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0121843","DOI":"10.1371\/journal.pone.0121843","article-title":"Morbidity and Mortality According to Latest CD4+ Cell Count among HIV Positive Individuals in South Africa Who Enrolled in Project Phidisa","volume":"10","author":"PH Maduna","year":"2015","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/135965350901400414","article-title":"HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme","volume":"14","author":"C Orrell","year":"2009","journal-title":"Antivir Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1004722","DOI":"10.1371\/journal.ppat.1004722","article-title":"Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds","volume":"11","author":"W-L Yang","year":"2015","journal-title":"PLOS Pathog"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"L Wittkop","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/QAD.0000000000000298","article-title":"Estimating per-act HIV transmission risk","volume":"28","author":"P Patel","year":"2014","journal-title":"AIDS"},{"key":"ref25","article-title":"Rapid Assessment of HIV Prevention, Care and Treatment Programming for MSM in South Africa","year":"2013","journal-title":"Rapid Assessment of HIV Prevention, Care and Treatment Programming for MSM in South Africa"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/tmi.12079","article-title":"The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting","volume":"18","author":"AT Brennan","year":"2013","journal-title":"Trop Med Int Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jac\/dkw358","article-title":"HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa","volume":"72","author":"K Steegen","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"RK Gupta","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"ref29","first-page":"239","article-title":"Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output from a Computer Code","volume":"21","author":"MD Mckay","year":"1979","journal-title":"A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/QAI.0000000000001173","article-title":"Sexual Behaviors and HIV Status: A Population-Based Study Among Older Adults in Rural South Africa","volume":"74","author":"MS Rosenberg","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/jmv.22143","article-title":"Resistance to antiretroviral drugs in newly diagnosed, young treatment-na\u00efve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa","volume":"83","author":"R Parboosing","year":"2011","journal-title":"J Med Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/aid.2015.0225","article-title":"Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa","volume":"32","author":"J Manasa","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e0166305","DOI":"10.1371\/journal.pone.0166305","article-title":"Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey","volume":"11","author":"K Steegen","year":"2016","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QAI.0b013e3182618f05","article-title":"Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients","volume":"61","author":"EL Yanik","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1473-3099(11)70149-9","article-title":"HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study","volume":"11","author":"RL Hamers","year":"2011","journal-title":"Artic Lancet Infect Dis"},{"key":"ref36","article-title":"FOR THE PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV (PMTCT) AND THE MANAGEMENT OF HIV IN CHILDREN, ADOLESCENTS AND ADULTS NATIONAL CONSOLIDATED GUIDELINES","year":"2014","journal-title":"FOR THE PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV (PMTCT) AND THE MANAGEMENT OF HIV IN CHILDREN, ADOLESCENTS AND ADULTS NATIONAL CONSOLIDATED GUIDELINES"},{"key":"ref37","article-title":"WHO\u2019s Response","year":"2018","journal-title":"WHO\u2019s Response"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1016\/S2352-3018(17)30152-2","article-title":"Dolutegravir as maintenance monotherapy for HIV (DOMONO): a phase 2, randomised non-inferiority trial","volume":"4","author":"I Wijting","year":"2017","journal-title":"Lancet HIV"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/jac\/dky093","article-title":"Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial","volume":"73","author":"JL Blanco","year":"2018","journal-title":"J Antimicrob Chemother"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007083","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T19:28:17Z","timestamp":1663788497000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007083"}},"subtitle":[],"editor":[{"given":"Rodolphe","family":"Thiebaut","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007083","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1007083","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]}}}